MAD2L1 and breast cancer: However, in another previous study conducted by Aclavicek et al. 22, the genetic variations in the major mitotic checkpoint genes, including MAD1L1 and MAD2L1, were found not to be significantly associated with the risk of familial breast cancer risk.